PRTN3 and rheumatoid arthritis: In the 2000s, ACPA testing became part of the diagnosis of RA and we wondered whether, in the roughly one third of our RA patients without ACPAs, we could identify other antigen/antibody systems that could prove helpful for diagnosis.